D.A. Davidson & CO. Has $1.64 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

D.A. Davidson & CO. increased its position in HCA Healthcare, Inc. (NYSE:HCA) by 61.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,042 shares of the company’s stock after purchasing an additional 1,536 shares during the quarter. D.A. Davidson & CO.’s holdings in HCA Healthcare were worth $1,643,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC increased its holdings in shares of HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after acquiring an additional 2,397,883 shares during the last quarter. Dai ichi Life Insurance Company Ltd raised its position in shares of HCA Healthcare by 12.6% in the third quarter. Dai ichi Life Insurance Company Ltd now owns 30,377 shares of the company’s stock valued at $12,346,000 after purchasing an additional 3,407 shares during the period. Private Trust Co. NA boosted its holdings in shares of HCA Healthcare by 16.4% during the 3rd quarter. Private Trust Co. NA now owns 1,137 shares of the company’s stock worth $462,000 after buying an additional 160 shares during the period. Hancock Whitney Corp raised its holdings in HCA Healthcare by 5.2% in the 3rd quarter. Hancock Whitney Corp now owns 4,111 shares of the company’s stock valued at $1,671,000 after acquiring an additional 205 shares during the period. Finally, Independent Advisor Alliance boosted its holdings in shares of HCA Healthcare by 20.5% during the third quarter. Independent Advisor Alliance now owns 1,142 shares of the company’s stock worth $464,000 after acquiring an additional 194 shares during the period. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of several recent research reports. Barclays reduced their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price on the stock. TD Cowen reduced their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Finally, Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $400.00 to $320.00 in a research report on Monday, November 25th. One analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $380.29.

HCA Healthcare Stock Up 0.5 %

Shares of NYSE:HCA opened at $327.22 on Friday. The company has a market capitalization of $82.88 billion, a PE ratio of 14.69, a price-to-earnings-growth ratio of 1.25 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $246.60 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The company has a fifty day moving average of $371.88 and a 200-day moving average of $358.61.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insiders Place Their Bets

In related news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 in the last ninety days. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.